MUMBAI, India, Aug. 12 -- Intellectual Property India has published a patent application (202617042340 A) filed by Trimt Gmbh on April 02, 2026, for Functionalized Peptides For In-Vivo Addressing Of Pd-L1 Expression.
Inventor includes Notni, Johannes.
The application for the patent was published on August 07, 2026, under issue no. 32/2026.
Abstract: The present invention provides conjugate compounds as well as radiotracers and radiopharmaceuticals comprising the same as well as their use in the imaging of PD-L1 expression. This allows to determine whether a patient of interest is suitable for treatment with immune checkpoint inhibitor therapy. Pharmaceutical compositions, kit, methods of treatment as well as methods of synthesis are also provided.
Disclaimer: Curated by HT Syndication.
